Zoeken | SocialyTime

Aryan Mhatre toegevoegd een audio Art
2026-01-05 12:53:01 -

Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights
"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...

0 Reacties 0 aandelen 4K Views 0 voorbeeld

Please log in to like, share and comment!
Komal Galande toegevoegd een audio Art
2026-04-06 04:48:01 -

Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?
Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...

0 Reacties 0 aandelen 680 Views 0 voorbeeld

Please log in to like, share and comment!
Komal Galande toegevoegd een audio Drinks
2026-04-06 08:04:55 -

Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?
Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...

0 Reacties 0 aandelen 721 Views 0 voorbeeld

Please log in to like, share and comment!
Subhayan Mayra toegevoegd een audio Other
2026-04-22 10:40:17 -

TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034
According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...

0 Reacties 0 aandelen 148 Views 0 voorbeeld

Please log in to like, share and comment!